209 related articles for article (PubMed ID: 33639061)
1. Circulating Biomarkers for the Early Diagnosis of Gastrointestinal Cancers.
Nellore J; Narayan AS; Sunkar S; Nachiyar CV; Jayakrishna T; Peela S
Crit Rev Oncog; 2020; 25(4):335-354. PubMed ID: 33639061
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Application of Circulating Tumor Cells and DNAs as Prognostic and Predictive Biomarkers in Gastrointestinal Cancer.
Memarpour S; Khalili-Tanha G; Ghannad AA; Razavi MS; Joudi M; Joodi M; Ferns GA; Hassanian SM; Khazaei M; Avan A
Curr Cancer Drug Targets; 2021; 21(8):676-688. PubMed ID: 33719973
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation detection technology and plasma-based methylation biomarkers in screening of gastrointestinal carcinoma.
Cao M; Zhang C; Zhou L
Epigenomics; 2021 Aug; 13(16):1327-1339. PubMed ID: 34369810
[TBL] [Abstract][Full Text] [Related]
4. The potential of liquid biopsies in gastrointestinal cancer.
Wu C; Zhang J; Li H; Xu W; Zhang X
Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
[TBL] [Abstract][Full Text] [Related]
5. Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers.
Shigeyasu K; Toden S; Zumwalt TJ; Okugawa Y; Goel A
Clin Cancer Res; 2017 May; 23(10):2391-2399. PubMed ID: 28143873
[TBL] [Abstract][Full Text] [Related]
6. Novel Biomarkers in the Diagnosis of Benign and Malignant Gastrointestinal Diseases.
Jonaitis P; Kiudelis V; Streleckiene G; Gedgaudas R; Skieceviciene J; Kupcinskas J
Dig Dis; 2022; 40(1):1-13. PubMed ID: 33647906
[TBL] [Abstract][Full Text] [Related]
7. Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers.
Sutton TL; Walker BS; Wong MH
Cell Mol Gastroenterol Hepatol; 2019; 8(4):595-607. PubMed ID: 31319228
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsies in gastrointestinal malignancies: when is the big day?
Lopez A; Harada K; Mizrak Kaya D; Dong X; Song S; Ajani JA
Expert Rev Anticancer Ther; 2018 Jan; 18(1):19-38. PubMed ID: 29202614
[TBL] [Abstract][Full Text] [Related]
9. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
[TBL] [Abstract][Full Text] [Related]
10. The current state of molecular profiling in gastrointestinal malignancies.
Mukherji R; Yin C; Hameed R; Alqahtani AZ; Kulasekaran M; He AR; Weinberg BA; Marshall JL; Hartley ML; Noel MS
Biol Direct; 2022 Jun; 17(1):15. PubMed ID: 35668531
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha MA; Seshacharyulu P; Krishn SR; Pai P; Rachagani S; Jain M; Batra SK
Curr Pharm Des; 2014; 20(33):5287-97. PubMed ID: 24479799
[TBL] [Abstract][Full Text] [Related]
12. Circulating biomarkers for early detection and clinical management of colorectal cancer.
Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
[TBL] [Abstract][Full Text] [Related]
13. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N; Druce PE; Snudden C; Milley KM; Boscott R; Behiyat D; Saji S; Martinez-Gutierrez J; Oberoi J; Funston G; Messenger M; Emery J; Walter FM
Adv Ther; 2021 Feb; 38(2):793-834. PubMed ID: 33306189
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
[TBL] [Abstract][Full Text] [Related]
15. Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Loaiza-Bonilla A; Benson AB; Grothey A; Karimi M; Klempner SJ; Lin D; Mahtani R; Soares HP
Oncologist; 2021 Aug; 26(8):651-659. PubMed ID: 33650740
[TBL] [Abstract][Full Text] [Related]
16. Circulating tumour cells and DNA as liquid biopsies in gastrointestinal cancer.
Nordgård O; Tjensvoll K; Gilje B; Søreide K
Br J Surg; 2018 Jan; 105(2):e110-e120. PubMed ID: 29341153
[TBL] [Abstract][Full Text] [Related]
17. Cell-free RNA for the liquid biopsy of gastrointestinal cancer.
Xing S; Zhu Y; You Y; Wang S; Wang H; Ning M; Jin H; Liu Z; Zhang X; Yu C; Lu ZJ
Wiley Interdiscip Rev RNA; 2023; 14(5):e1791. PubMed ID: 37086051
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in blood-based and artificial intelligence-enhanced approaches for gastrointestinal cancer diagnosis.
Li LS; Guo XY; Sun K
World J Gastroenterol; 2021 Sep; 27(34):5666-5681. PubMed ID: 34629793
[TBL] [Abstract][Full Text] [Related]
19. Circulating metabolites as potential biomarkers for the early detection and prognosis surveillance of gastrointestinal cancers.
Song G; Wang L; Tang J; Li H; Pang S; Li Y; Liu L; Hu J
Metabolomics; 2023 Apr; 19(4):36. PubMed ID: 37014438
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as a novel class of diagnostic biomarkers in gastrointestinal tumors detection: a meta-analysis based on 42 articles.
Wang R; Wen H; Xu Y; Chen Q; Luo Y; Lin Y; Luo Y; Xu A
PLoS One; 2014; 9(11):e113401. PubMed ID: 25406082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
